BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 2:46:00 PM | Browse: 970 | Download: 790
Publication Name World Journal of Gastroenterology
Manuscript ID 6272
Country/Territory United States
Received
2013-10-11 17:08
Peer-Review Started
2013-10-12 16:05
To Make the First Decision
2013-12-26 11:39
Return for Revision
2013-12-26 17:54
Revised
Second Decision
2014-05-05 08:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-05 09:46
Articles in Press
2014-05-23 10:17
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-06-04 13:43
Publish the Manuscript Online
2014-06-21 13:56
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Emerging therapeutic options for the management of hepatitis C infection
Manuscript Source Invited Manuscript
All Author List J Richard Thompson
Funding Agency and Grant Number
Corresponding Author J Richard Thompson, PhD, MBA, BCPS, Department of Pharmacy Practice, One University Park Drive, Lipscomb University College of Pharmacy, Nashville, TN 37204, United States. richard.thompson@lipscomb.edu
Key Words Hepatitis C; Pharmacotherapy; Interferon; Ribavirin; Protease inhibitors; Polymerase inhibitors; Cyclophilin inhibitors
Core Tip A plethora of new agents for the management of hepatitis C promising higher response rates and better tolerated side effect profiles is upon us. Many of these new drugs in development utilize novel pharmacologic mechanisms and may replace older more toxic therapies such as interferon and ribavirin. In addition, once daily dosing and shorter treatment durations should help improve adherence and optimize therapeutic outcomes for hepatitis C infection.
Publish Date 2014-06-21 13:56
Citation Thompson JR. Emerging therapeutic options for the management of hepatitis C infection. World J Gastroenterol 2014; 20(23): 7079-7088
URL http://www.wjgnet.com/1007-9327/full/v20/i23/7079.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i23.7079
Full Article (PDF) WJG-20-7079.pdf
Full Article (Word) WJG-20-7079.doc
Manuscript File 6272-Review.docx
Answering Reviewers 6272-Answering reviewers.pdf
Copyright License Agreement 6272-Copyright assignment.pdf
Peer-review Report 6272-Peer review.pdf
Scientific Editor Work List 6272-Scientific editor work list.pdf